ENP107: Compounded Obesity Medications

Endocrine News Podcast by Endocrine Society

Dec 3, 202511:49Science & Medicine

Technically known as glucagon-like peptide-1 receptor agonists, or GLP-1, these drugs have been around for years for treating diabetes. Now it seems most people think of GLP-1 drugs as medications to lose weight, and the...

Related Episodes

Continue listening to more episodes from Endocrine News Podcast.

Bisphenols and the Thyroid

Aug 14, 2026 - 11:39

This episode looks at bisphenols and the thyroid, asking questions such as: What is BPA? Where is it foun...

Impact of Androgen Receptors on Estrogen Receptor-Positive Breast Cancer Microenvironments

Aug 3, 2026 - 20:04

Estrogen receptor positive breast cancer (ER+ BC) is the most frequently diagnosed subtype of BC with con...

ENP113: Clinical Practice Guideline on Central Precocious Puberty

Jun 25, 2026 - 17:40

The Endocrine Society recently released a new Clinical Practice Guideline (CPG) on Central Precocious Pub...

ENP112: Osteoporosis and the SABRE Project

May 18, 2026 - 24:00

The U.S. Food and Drug Administration recently qualified "total hip bone mineral density" as a surrogate...

ENP111: Addressing the Endocrine Workforce Shortage

Feb 25, 2026 - 30:12

The endocrine workforce shortage is affecting the lives of endocrinologists and the patients they treat....

ENP110: Hypercortisolism and T2D

Jan 21, 2026 - 20:03

For some people, diabetes can be very hard to control, even with the standard glucose-lowering therapies....

ENP109: Anti-Obesity Medications (CME credit available)

Jan 7, 2026 - 13:15

In recent years, we have seen tremendous growth not just in the popularity of anti-obesity medications, b...

ENP108: AI and Robotics in Surgery

Dec 17, 2025 - 10:28

In the last five years, the field of artificial intelligence and robotics has taken off and has become a...